Patents by Inventor Yulin CAO
Yulin CAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240110135Abstract: A micro-organ specificity maintenance system includes a micro-organ specificity parallel reactor module for storing and culturing vascularized micro-organs; a feeding module for feeding culture solutions to the micro-organ specificity parallel reactor module; an injection module for injecting medical solutions containing traditional Chinese medicine micromolecules into the micro-organ specificity parallel reactor module; a micro-organ circulation coupling module for transmitting venous flow and arterial flow to the micro-organ specificity parallel reactor module; and a micro-organ neural coupling module for transmitting neural network signals to the micro-organ specificity parallel reactor module. The micro-organ specificity maintenance system provided in the disclosure has the advantage that an extracorporeal circulation system and internal vascular systems of complex organs are organically integrated and connected.Type: ApplicationFiled: December 20, 2022Publication date: April 4, 2024Applicants: Tangyi Holding (Shenzhen) Co., Ltd.Inventor: Yulin CAO
-
Patent number: 11946073Abstract: A method for non-enzymatic 3D culture and amplification of mesenchymal stem cells (MSCs) includes the followings steps: preparing PLGA porous microspheres; preparing a PLGA-PEG-PLGA thermosensitive coating microcarrier; culturing and amplifying MSCs; and performing non-enzymatic separation of MSCs, including reducing a culture temperature to below a critical phase transition temperature, and centrifuging a culture medium to collect stem cells. The present invention adopts the method for non-enzymatic 3D culture and amplification of MSCs, wherein the PLGA porous microspheres are used as a cell culture microcarrier scaffold and the thermosensitive hydrogel PLGA-PEG-PLGA is coated on surfaces of such microspheres, without needing additional enzymolysis process, thus efficiently amplifying the stem cells.Type: GrantFiled: May 8, 2022Date of Patent: April 2, 2024Assignees: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) LimitedInventors: Bin Zheng, Yulin Cao, Wenchang Peng, Shixiang Cheng
-
Publication number: 20240091282Abstract: A probiotic microcapsule for the treatment of reproductive tract infection and a preparation method and application thereof are provided. The probiotic microcapsule is obtained by coating probiotics with the coating material. The probiotics include one or several of Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus fermentum, Lactobacillus reuteri, Lactobacillus crimpus, Lactobacillus brevis, Lactobacillus salivary, Lactobacillus plantarum, Lactobacillus acidophilus, and Lactobacillus bulgaricus. As probiotics screened in reproductive tract, it has high safety; It endows probiotics with adhesion function to ensure their effect in the reproductive tract; It overcomes the defects of current antibiotic therapy; It is expected to be used in a variety of reproductive tract infectious diseases.Type: ApplicationFiled: October 18, 2022Publication date: March 21, 2024Applicants: Tangyi Biomedical (Tianjin) Co., Ltd., Tangyi Holding (Shenzhen) Co., Ltd.Inventors: Bin ZHENG, Qinglu GUO, Yulin CAO, Shixiang CHENG, Zhihui BAI
-
Publication number: 20240091514Abstract: A transdermal double-layer microneedle based on hydrogen producing probiotics and its preparation method and application thereof are provided. The transdermal double-layer microneedle consists of a needle body and a backing layer. The raw material of the needle body includes hyaluronic acid and hyaluronidase. The raw material of the backing layer includes methacrylate anhydride gelatin and silk fibroin protein. The hydrogen producing bacteria are loaded in the microneedles, and the pore size of the matrix material is lower than the diameter of the probiotics, which will not lead to the leakage of bacteria and has high safety. Treatment of inflammatory skin diseases by gas has low side effects. The needle tip is loaded with hyaluronidase to increase the tissue space and improve the effect of gas treatment. It is expected to be used in psoriasis and other inflammatory skin diseases.Type: ApplicationFiled: October 18, 2022Publication date: March 21, 2024Applicants: Tangyi Biomedical (Tianjin) Co., Ltd., Tangyi Holding (Shenzhen) Co., Ltd.Inventors: Bin ZHENG, Qinglu GUO, Yulin CAO, Shixiang CHENG, Zhihui BAI
-
Publication number: 20240084432Abstract: The disclosure provides a method for heat-treating a boron steel, which includes: carburizing a boron steel on a surface thereof to obtain a carburized boron steel; austenitizing the carburized boron steel at a temperature of 885-895° C. for 25-35 min, to obtain an austenitized boron steel; sequentially subjecting the austenitized boron steel to an oil quenching and a tempering, wherein the oil quenching is performed at a temperature of 55-65° C. for 29-31 min.Type: ApplicationFiled: November 3, 2021Publication date: March 14, 2024Inventors: Yulin JU, Xiaonong CHENG, Zhizhong YUAN, Shun GUO, Rui LUO, Fuyang CAO, Hao HUANG
-
Publication number: 20240087669Abstract: A multi-micro-organ culture and interaction big data analysis system based on cloud native includes a multi-micro-organ culture database, a learning model establishment module, a feature extraction terminal, a multi-micro-organ visualization terminal and a multi-micro-organ learning terminal, the multi-micro-organ culture database is connected to the learning model establishment module by means of a signal line, the learning model establishment module is connected to the feature extraction terminal by means of a signal line, the feature extraction terminal is connected to the multi-micro-organ visualization terminal and the multi-micro-organ learning terminal separately by means of signal lines, and the feature extraction terminal includes a micro-organ function extraction module, a micro-organ interaction extraction module and a medicine response extraction module.Type: ApplicationFiled: January 6, 2023Publication date: March 14, 2024Applicants: Tangyi Holding (Shenzhen) Co., Ltd.Inventor: Yulin CAO
-
Publication number: 20240086535Abstract: A multi-micro-organ system data processing system based on a field programmable gate array includes a data collection module, a programmable processing terminal, a server and a display terminal, the data collection module is connected to the programmable processing terminal by means of a signal line, the programmable processing terminal is connected to the server, the server is connected to the display terminal, and the programmable processing terminal includes a data processing chip, a file management module, a cache module, a high-speed transmission module, a safety protection module and a fault alarm module. According to the disclosure, flow data, temperature data, CO2 concentration data, cell activity data, functional index data and electroencephalogram signals can be synchronously collected, quickly processed, and then cached and transmitted at a high speed, so as to obviously improve data processing efficiency.Type: ApplicationFiled: December 22, 2022Publication date: March 14, 2024Applicants: Tangyi Holding (Shenzhen) Co., Ltd.Inventor: Yulin CAO
-
Publication number: 20240082473Abstract: A multi-micro-organ extracorporeal circulation and neural network maintenance system, includes a plurality of organ specificity maintenance systems, and each independent organ specificity maintenance system is connected to a human brain organ specificity maintenance system and a heart organ specificity maintenance system in a two-way manner by means of a simulated neural network.Type: ApplicationFiled: January 6, 2023Publication date: March 14, 2024Applicants: Tangyi Holding (Shenzhen) Co., Ltd.Inventor: Yulin CAO
-
Patent number: 11826461Abstract: The present invention discloses a nano-armored single cell product, comprising a liposome and probiotics encapsulated by the liposome, wherein the probiotics are fermented to produce gamma-aminobutyric acid (GABA) that alleviates the activation of an inflammatory response in substantia nigra inducedin a MPTP induced PD model, thus mitigating an inflammatory injury to dopaminergic neurons in substantia nigra and having a neuroprotective effect; encapsulation of the probiotics by the liposome can protect the probiotics from strong acids and digestive enzymes in gastric acid.Type: GrantFiled: October 18, 2021Date of Patent: November 28, 2023Assignees: TANGYI HOLDINGS (SHENZHEN) LIMITED, HEALTHINA STEM CELL INDUSTRY PLATFORM (TIANJIN) LIMITEDInventors: Bin Zheng, Yulin Cao, Bowen Li, Wei Sun, Shixiang Cheng
-
Patent number: 11793840Abstract: The present invention discloses a nano-armored single cell product, comprising a liposome and probiotics encapsulated by the liposome, wherein the probiotics are fermented to produce gamma-aminobutyric acid (GABA) that alleviates the activation of an inflammatory response in substantia nigra inducedin a MPTP induced PD model, thus mitigating an inflammatory injury to dopaminergic neurons in substantia nigra and having a neuroprotective effect; encapsulation of the probiotics by the liposome can protect the probiotics from strong acids and digestive enzymes in gastric acid.Type: GrantFiled: October 18, 2021Date of Patent: October 24, 2023Assignees: Tangyi Holdings(Shenzhen) Limited, Healthina Stem Cell Industry Platform (Tianjin) LimitedInventors: Bin Zheng, Yulin Cao, Wei Sun, Qinglu Guo, Shixiang Cheng
-
Publication number: 20230287352Abstract: A method for non-enzymatic 3D culture and amplification of mesenchymal stem cells (MSCs) includes the followings steps: preparing PLGA porous microspheres; preparing a PLGA-PEG-PLGA thermosensitive coating microcarrier; culturing and amplifying MSCs; and performing non-enzymatic separation of MSCs, including reducing a culture temperature to below a critical phase transition temperature, and centrifuging a culture medium to collect stem cells. The present invention adopts the method for non-enzymatic 3D culture and amplification of MSCs, wherein the PLGA porous microspheres are used as a cell culture microcarrier scaffold and the thermosensitive hydrogel PLGA-PEG-PLGA is coated on surfaces of such microspheres, without needing additional enzymolysis process, thus efficiently amplifying the stem cells.Type: ApplicationFiled: May 8, 2022Publication date: September 14, 2023Applicants: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) LimitedInventors: Bin ZHENG, Yulin CAO, Wenchang PENG, Shixiang CHENG
-
Publication number: 20230277825Abstract: An mRNA vaccine microneedle product includes a backing and a mRNA vaccine solution-containing microneedle array attached to a side of the backing, wherein the mRNA solution-containing microneedle array includes several microneedles, and each microneedle contains a matrix and mRNA loaded in the matrix. The present invention adopts the mRNA vaccine microneedle product as well as a preparation method and an application thereof, and such microneedle product can realize a rapid humoral immunity after being administered to the skins of animal bodies (especially human bodies), which solves the problems of traditional vaccination, such as muscular pain and multiple injections.Type: ApplicationFiled: May 13, 2022Publication date: September 7, 2023Applicants: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings (Shenzhen) LimitedInventors: Bin ZHENG, Yulin CAO, Wei SUN, Shixiang CHENG
-
Publication number: 20230277827Abstract: A recombinant subunit vaccine microneedle product includes a backing and a recombinant subunit lung-associated virus vaccine solution-containing microneedle array attached to a side of the backing, wherein the recombinant subunit lung-associated virus vaccine solution-containing microneedle array includes a plurality of microneedles, wherein each microneedle contains a matrix and a recombinant subunit loaded in the matrix. The present invention adopts the recombinant subunit vaccine microneedle product as well as a preparation method and an application thereof, wherein such microneedle product can realize a rapid humoral immunity after being administered to the skins of animal bodies (especially human bodies), which solves the problems of traditional lung-associated virus vaccine injection, such as muscular pain and multiple injections.Type: ApplicationFiled: May 24, 2022Publication date: September 7, 2023Applicants: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) LimitedInventors: Bin ZHENG, Yulin CAO, Wei SUN, Shixiang CHENG
-
Publication number: 20230277826Abstract: An inactivated virus vaccine microneedle product includes a backing and an inactivated virus-containing microneedle array attached to a side of the backing, wherein the inactivated virus-containing microneedle array includes a plurality of microneedles, and each microneedle contains a matrix and an inactivated virus loaded in the matrix. The present invention adopts the inactivated virus vaccine microneedle product as well as a preparation method and an application thereof, and such microneedle product realizes efficient transdermal absorption of a vaccine by loading an inactivated virus in the microneedle product after being administered to the skin, and a long-acting stable release of a vaccine is achieved, which solves the problems of traditional vaccination, such as muscular pain and multiple injections.Type: ApplicationFiled: May 21, 2022Publication date: September 7, 2023Applicants: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) LimitedInventors: Bin ZHENG, Yulin CAO, Wei SUN, Shixiang CHENG
-
Publication number: 20230270779Abstract: An exosome hydrogel for treating severe respiratory diseases is provided and includes a temperature-sensitive hydrogel and an exosome; wherein the temperature-sensitive hydrogel is PLGA-PEG-PLGA. According to the present invention, PLGA-PEG-PLGA generates a hydrogel exosome through a phase transition at a body temperature, and the hydrogel stays in lungs for a longer time than common exosomes, thereby making the exosome remain at an infection site and producing a better therapeutic effect. The exosome hydrogel features high safety, is suitable for promotion, and has good potential in medical treatment.Type: ApplicationFiled: March 4, 2022Publication date: August 31, 2023Applicants: Tangyi Holdings(Shenzhen) Limited, Healthina Stem Cell Industry Platform (Tianjin) LimitedInventors: Bin ZHENG, Yulin CAO, Tingting HUA, Shixiang CHENG
-
Publication number: 20230272426Abstract: The method of preparing polyethyleneimine-lipid nanoparticles (PEI-LNPs) for transfecting stem cells includes the following steps: S1, adding anhydride to a PEI solution to produce polycarboxylic acid; S2, dissolving the PEI-LNPs from S1, together with DPPC, DPPG, DPPE-PEG-COOH and cholesterol in chloroform, dissolving cGAMP in a water and then adding to such chloroform solution, and performing vacuum evaporation to remove the chloroform; S3, adding PBS for hydration, and performing ultrasonication to obtain liposomes; and S4, adding EDC/NHS to the liposome solution obtained for reaction for 15 min, then adding mRNA, and stirring the mixed solution to obtain a bionic virus nanovaccine. The prepared PEI-LNPs are used for delivering an mRNA vaccine and transfecting stem cells, wherein through a lipid PEI derivative library synthesized based on short-branched PEI with a variable length and hydrophobic tail substitution ratio, short-branched PEI can form a stable complex with the mRNA vaccine.Type: ApplicationFiled: July 12, 2022Publication date: August 31, 2023Applicants: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) LimitedInventors: Bin ZHENG, Yulin CAO, Tingting HUA, Shixiang CHENG
-
Publication number: 20230256081Abstract: A method for preparing an atomizing SARS-CoV-2 nanovaccine includes the followings steps: mimicking a structure of SARS-COV-2 with receptor binding domains (RBDs) of SARS-COV-2, by taking Poly(I:C) mimicking viral genetic materials as an immunoadjuvant, and electronegative liposomes that enter pulmonary macrophages efficiently as a viral capsid structure; adding a catalyst and an RBD antigen protein to a liposome solution, linking the antigen protein to a liposome surface, and obtaining a bionic virus nanovaccine after purification and freeze-drying treatment. Compared with conventional intramuscular and subcutaneous inoculation, the SARS-CoV-2 vaccine of the present invention features strong mucosal protection effect, high safety, extensive application, and excellent potential.Type: ApplicationFiled: April 14, 2022Publication date: August 17, 2023Applicants: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) LimitedInventors: Bin ZHENG, Yulin CAO, Tingting HUA, Shixiang CHENG
-
Publication number: 20230071574Abstract: The present invention discloses an anti-hair loss and hair growth integrated core-shell microneedle patch, comprising a backing and a core-shell microneedle array attached to one side of the backing, the core-shell microneedle array comprises a plurality of microneedles arranged on the backing to form an array, each microneedle comprises a shell substrate material and an internal core, and the shell substrate material is loaded with nano-enzyme for removing excessive active oxygen.Type: ApplicationFiled: October 18, 2021Publication date: March 9, 2023Inventors: Bin Zheng, Yulin Cao, Bowen Li, Wei Sun, Shixiang Cheng
-
Publication number: 20230065910Abstract: The present invention discloses a nano-armored single cell product, comprising a liposome and probiotics encapsulated by the liposome, wherein the probiotics are fermented to produce gamma-aminobutyric acid (GABA) that alleviates the activation of an inflammatory response in substantia nigra inducedin a MPTP induced PD model, thus mitigating an inflammatory injury to dopaminergic neurons in substantia nigra and having a neuroprotective effect; encapsulation of the probiotics by the liposome can protect the probiotics from strong acids and digestive enzymes in gastric acid.Type: ApplicationFiled: October 18, 2021Publication date: March 2, 2023Inventors: Bin Zheng, Yulin Cao, Wei Sun, Qinglu Guo, Shixiang Cheng
-
Patent number: 11511036Abstract: The infusion pump for stem cells includes a liquor storage device and an infusion pipe. The inner wall of the liquor storage sac of the liquor storage device and inner walls of the infusion pipe are provided with an anionic protective film to prevent stem cells from adhering to the infusion pump by mutual repulsion between anions. The infusion method includes checking an infusion pump for integrity, losing a liquor stop clamp, injecting a mixed liquor of stem cells and medicine, covering a protective cap, opening the liquor stop clamp, closing the liquor stop clamp for use, connecting an external cone joint with a venous cannula, and then opening the liquor stop clamp. The method also includes steadily placing the liquor storage sac on a horizontal plane using an auxiliary placing device, and after infusion ends, closing the liquor stop clamp, and disconnecting the external cone joint.Type: GrantFiled: August 11, 2016Date of Patent: November 29, 2022Assignee: BENING ZHEN HUIKANG BIOLOGICAL TECH. Co., Ltd.Inventors: Yulin Cao, Juntang Lin, Xiayun Li, Wei He, Shihong Liu, Chengqian Lu